Author

Yurong Cheng

University of FreiburgORCID 0009-0000-3409-949XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Assay:metabolomics· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Anna KöttgeniD· 2 shared Kai‐Uwe EckardtiD· 2 shared A. Rendon· 1 shared Adam P GiessiD· 1 shared Afshan SiddiqiD· 1 shared Alex Stuckey· 1 shared Alexander SieghartiD· 1 shared Alona SosinskyiD· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Anna KöttgenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintOct 17, 2023

Coupling of metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and resulting traits and diseases

Nora Scherer, Daniel Fässler, Oleg Borisov…·Anna Köttgen

The paper identifies gene-metabolite associations using exome sequencing and metabolomics, revealing graded effects of rare variants on traits and diseases.

2 citations

humanwhole-exome sequencing

𝕏 PostBluesky

Genetic & Genomic MedicineProceedings of the National Academy of SciencesPeer-reviewedAug 10, 2022

An intermediate effect size variant in UMOD confers risk for chronic kidney disease

Eric Gregory Olinger, Céline Schaeffer, Kendrah O. Kidd…·Magdalena Zarowiecki

The paper identifies an intermediate-effect variant in UMOD associated with chronic kidney disease risk and shows it has reduced disease severity compared to canonical ADTKD mutations.

49 citationstop 2%

humanGWAS summary statistics

𝕏 PostBluesky